Results for tag: "Radicava"

Radicava is a drug used to treat amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disorder. It is a central nervous system (CNS) drug, meaning it acts on the brain and spinal cord to reduce the symptoms of ALS. Radicava is administered intravenously and works by reducing the levels of oxidative stress in the body, which can damage nerve cells and lead to ALS. It is the only approved drug for ALS in the United States and is approved in several other countries. Radicava is marketed by Mitsubishi Tanabe Pharma America, Inc. in the United States and by Mitsubishi Tanabe Pharma Corporation in other countries. Other companies in the market include Biogen, Novartis, and Sanofi. Show Less Read more